Proathlete Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$165K Buy
1,921
+123
+7% +$12K 0.04% 84
2026
Q2
$186K Buy
1,798
+14
+0.8% +$1.25K 0.05% 76
2026
Q1
$128K Buy
1,784
+16
+0.9% +$1.23K 0.04% 82
2025
Q4
$140K Buy
1,768
+15
+0.9% +$1.18K 0.04% 81
2025
Q3
$132K Buy
1,753
+18
+1% +$1.23K 0.04% 81
2025
Q2
$120K Buy
1,735
+16
+0.9% +$1.05K 0.04% 81
2025
Q1
$116K Buy
+1,719
New +$103K 0.04% 81

Other funds holding CVS

Proathlete Wealth Management's CVS Position: Q3 2026 in Review

Proathlete Wealth Management increased its CVS Health (CVS) stake by 6.8% in Q3 2026, buying an estimated $12K and bringing the position to 1,921 shares worth $165K. The position accounts for 0.04% of the portfolio, ranked #84.

Proathlete Wealth Management first reported a position in CVS in Q1 2025 and has held it in 7 quarters since. The position peaked at $186K in Q2 2026. 1,987 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Proathlete Wealth Management held 1,921 shares of CVS Health worth $165K as of Q3 2026.
  • Proathlete Wealth Management bought 123 CVS Health shares in Q3 2026, an estimated $12K.
  • CVS Health made up 0.04% of Proathlete Wealth Management's portfolio in Q3 2026, its #84 holding.
  • Proathlete Wealth Management first reported a position in CVS Health in Q1 2025 and has held it in 7 quarters since.
  • Proathlete Wealth Management's CVS Health position peaked at $186K in Q2 2026.
  • 1,987 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Proathlete Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.